Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States
COVID-19 diagnoses were associated with an increased risk of GBS and ITP in both data sources and study designs. Increased risks of other neurologic/immune-mediated AEs cannot be ruled out.
Authors
- Steven A. Anderson
- Tainya C. Clarke (ORCID: https://orcid.org/0000-0002-8085-5601)
- Pablo Freyria Duenas
- Mary S. Anthony (ORCID: https://orcid.org/0000-0002-5201-1794)
- J. Bradley Layton (ORCID: https://orcid.org/0000-0003-0994-5820)
- Angela Cheng (ORCID: https://orcid.org/0009-0009-0092-9606)
- Timothy Burrell (ORCID: https://orcid.org/0000-0001-7973-7803)
- Hai Lyu (ORCID: https://orcid.org/0000-0001-5041-7902)
- Christine Bui (ORCID: https://orcid.org/0000-0002-3568-3097)
- Yangping Chen
- Joann F. Gruber (ORCID: https://orcid.org/0000-0003-2831-9315)
- Morgan M. Richey (ORCID: https://orcid.org/0000-0003-4533-8948)
- Mollie M. McKillop (ORCID: https://orcid.org/0000-0002-4805-5989)
- Yoganand Chillarige (ORCID: https://orcid.org/0000-0002-8020-6839)
- Arnstein Lindaas (ORCID: https://orcid.org/0009-0002-2568-3509)
- Patricia C. Lloyd
- Jeffrey Beers (ORCID: https://orcid.org/0000-0001-5363-0434)
- Stella G. Muthuri (ORCID: https://orcid.org/0000-0003-0987-7450)
- Richard A. Forshee (ORCID: https://orcid.org/0000-0002-5805-2837)
- Lisa Kowarski (ORCID: https://orcid.org/0000-0003-2392-0494)
- Azadeh Shoaibi
- Minya Sheng
- Shelby S. Fisher
Institutions
- Center for Biologics Evaluation and Research (US)
- RTI International (US)
- Acumen (United States) (US)
- RTI Health Solutions (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1371/journal.pone.0333704
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00